Anti-VEGF Maintains Visual Acuity Gains At 1 Year In Patients With Neovascular AMD

Pegaptanib as induction-maintenance therapy improved visual acuity and stabilized center point thickness in patients with neovascular age-related macular degeneration, a study found.

Full Story →